Regulation of body weight and carcass composition by sibutramine in rats

Obesity Research

Volumn 10, Issue 3, 2002, Pages 173-181

  Strack, Alison M ^a   Shu, Joanne ^a   Camacho, Ramon ^a   Gorski, Judith N ^a   Murphy, Beth ^a   MacIntyre, D Evan ^a   Hickey, Gerard J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Anorexia; Feeding; Serotonin

Indexed keywords

ANOREXIGENIC AGENT; CYCLOBUTANE DERIVATIVE; SIBUTRAMINE;

ADIPOSE TISSUE; ANIMAL; ARTICLE; BODY COMPOSITION; BODY WEIGHT; DRUG EFFECT; EATING; MALE; METABOLISM; RAT; SPRAGUE DAWLEY RAT;

ADIPOSE TISSUE; ANIMALS; APPETITE DEPRESSANTS; BODY COMPOSITION; BODY WEIGHT; CYCLOBUTANES; EATING; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0036512888     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2002.27     Document Type: Article

References (33)

1. Holtz C, Smith TM, Winters FD. Childhood obesity. J Am Osteopath Assoc. 1999;99:366-71.
2. Must A, Strauss RS. Risks and consequences of childhood and adolescent obesity. Int J Obes Relat Metab Disord. 1999; 23:S2-S11.
3. Heal DJ, Aspley S, Prow MR, Jackson HC, Martin KF, Cheetham SC. Sibutramine: a novel anti-obesity drug: a review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine. Int J Obes Relat Metab Disord. 1998;22:S18-S28.
4. Jackson HC, Bearham MC, Hutchins LJ, Mazurkiewicz SE, Needham AM, Heal DJ. Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the rat. Br J Pharmacol. 1997;121:1613-8.
5. Hanotin C, Thomas F, Jones SP, Leutenegger E, Drouin P. Efficacy and tolerability of sibutramine in obese patients: a dose ranging study. Int J Obes Relat Metab Disord. 1998;22: 32-8.
6. Ryan DH, Kaiser P, Bray GA. Sibutramine: a novel new agent for obesity treatment. Obes Res. 1995;3:553S-9S.
7. Chapelot D, Marmonier C, Thomas F, Hanotin C. Modalities of the food intake-reducing effect of sibutramine in humans. Physiol Behav. 2000;68:299-308.
8. Rolls BJ, Shide DJ, Thorwart ML, Ulbrecht JS. Sibutramine reduces food intake in non-dieting women with obesity. Obes Res. 1998;6:1-11.
9. Hansen DL, Toubro S, Stock MJ, Macdonald IA, Astrup A. The effect of sibutramine on energy expenditure and appetite during chronic treatment without dietary restriction. Int J Obes Relat Metab Disord. 1999;23:1016-24.
10. Walsh KM, Leen E, Lean MEJ. The effect of sibutramine on resting energy expenditure and adrenaline-induced thermogenesis in obese females. Int J Obes Relat Metab Disord. 1999;23:1009-15.
11. Seagle HM, Bessesen DH, Hill JO. Effects of sibutramine on resting metabolic rate and weight loss in overweight women. Obes Res. 1998;6:115-21.
12. Grignaschi G, Fanelli E, Scagnol I, Samanin, R. Studies on the role of serotonin receptor subtypes in the effect of sibutramine in various feeding paradigms in rats. Br J Pharmacol. 1999;127:1190-4.
13. Jackson HC, Needham AM, Hutchins LJ, Mazurkiewicz SE, Heal DJ. Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat. Br J Pharmacol. 1997;121:1758-62.
14. Levin BE, Dunn-Meynell AA. Sibutramine alters the central mechanisms regulating the defended body weight in diet-induced obese rats. Am J Physiol. 2000;279:R2222-R8.
15. Nakagawa T, Ukai K, Ohyama T, Gomita Y, Okamura H. Effects of chronic administration of sibutramine on body weight, food intake and motor activity in neonatally monosodium glutamate-treated obese female rats: relationship of antiobesity effect with monoamines. Exp Anim. 2000;49: 239-49.
16. Fantino M, Faion F, Rolland Y. Effect of dexfenfluramine on body weight set-point: study in the rat with hoarding behaviour. Appetite. 1986;7:115-26.
17. Rowland NE, Carlton J. Dexfenfluramine: effects on food intake in various animal models. Clin Neuropharmacol. 1988; 11:S33-S50.
18. Blundell JE, Lawton CL. Serotonin and dietary fat intake: effects of dexfenfluramine. Metabolism. 1995;44:33-7.
19. Thibault L, Booth DA. Macronutrient-specific dietary selection in rodents and its neural bases. Neurosci Biobehav Rev. 1999;23:457-528.
20. Blundell JE, Hill AJ. Effect of dextrofenfluramine on feeding and body weight: relationship with food composition and palatability. In: Vague J, Björntorp P, Guy-Grand B, Rebuffe-Scrive M, Vague P, eds. Metabolic Complications of Human Obesities. New York, NY: Elsevier Science Publishers BV; 1985, pp. 199-206.
21. Levin BE, Triscari J, Sullivan AC. Metabolic features of diet-induced obesity without hyperphagia in young rats. Am J Physiol. 1986;251:R433-R40.
22. Makan S, Bayley HS, Webber CE. Precision and accuracy of total body bone mass and body composition measurements in the rat using x-ray-based dual photon absorptiometry. Can J Physiol Pharmacol. 1997;75:1257-61.
23. Rose BS, Flatt WP, Martin RJ, Lewis RD. Whole body composition of rats determined by dual energy X-ray absorptiometry is correlated with chemical analysis. J Nutr. 1998; 128:246-50.
24. Connoley IP, Liu Y-L, Frost I, Reckless IP, Heal DJ, Stock MJ. Thermogenic effects of sibutramine and its metabolites. Br J Pharmacol. 1999;126:1487-95.
25. Vickers SP, Benwell KR, Porter RH, Bickerdike MJ, Kennett GA, Dourish CT. Comparative effects of continuous infusion of mCPP, Ro 60-0175 and d-fenfluramine on food intake, water intake, body weight and locomotor activity in rats. Br J Pharmacol. 2000;130:1305-14.
26. Neill JC, Cooper SJ. Evidence that d-fenfluramine anorexia is mediated by 5-HT1 receptors. Psychopharmacology. 1989; 85:111-4.
27. 2C serotonin receptors. Nature. 1995;374:542-6.
28. 2C receptor mutant mice. Psychopharmacology. 1999;143:309-14.
29. Lucas JJ, Yamamoto A, Scearce-Levie K, Saudou F, Hen R. Absence of fenfluramine-induced anorexia and reduced c-fos induction in the hypothalamus and central amygdaloid complex of serotonin 1B receptor knock-out mice. J Neurosci. 1998;18:5537-44.
30. Heal DJ, Prow M, Buckett WR. Effects of antidepressant drugs and electroconvulsive shock on pre- and postsynaptic α2-adrenoceptor function in the brain: rapid down-regulation by sibutramine hydrochloride. Psychopharmacology (Berlin). 1991;103:251-7.
31. Heal DJ, Butler SA, Hurst EM, Buckett WR. Antidepressant treatments, including sibutramine hydrochloride and electroconvulsive shock, decrease β1-but not β2-adrenoceptors in rat cortex. J Neurochem. 1989;53:1019-25.
32. Fone K, Austin R, Topham I, Kennett G, Punhani T. Effect of chronic m-CPP on locomotion, hypophagia, plasma corticosterone and 5-HT2C receptor levels in the rat. Br Pharmacol. 1998;123:1705-15.
33. Levin BE, Routh VH. Role of the brain in energy balance and obesity. Am J Physiol. 1996;271:R491-R500.